Trigyn Technologies Limited has informed the Exchange regarding Board meeting held on August 11, 2025.
TRIGYN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trigyn Technologies' board met on August 11, 2025 and approved unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). On a consolidated basis, revenue from operations fell to Rs. 22,449.99 lakhs from Rs. 24,194.44 lakhs in Q1 FY25, a decline of around 7%. Profit before tax dropped sharply to Rs. 71.65 lakhs from Rs. 1,211.35 lakhs, and the company reported a net loss of Rs. 460.86 lakhs versus a profit of Rs. 761.38 lakhs a year ago, translating to a loss per share of Rs. 1.50 versus earnings of Rs. 2.47. On a standalone basis, revenue dipped slightly to Rs. 3,541.02 lakhs and net loss widened to Rs. 499.02 lakhs (EPS of Rs. -1.62). The auditor (V. Rohatgi & Co.) issued an unqualified limited review but flagged several emphasis-of-matter issues, including two subsidiaries prepared on a going concern basis despite negative net worth, cumulative ECL provisions of Rs. 55.27 crores on receivables, non-recognition of Rs. 80 crores of quarterly guaranteed revenue from the APSFL contract due to collection uncertainty, a Rs. 9.08 crore GST demand, the terminated Nashik smart parking project in arbitration, and reclassification of the Switzerland subsidiary as a discontinued operation. Separately, Bhavana Rao Potluri was redesignated as Executive Vice Chair, and the board approved setting up a step-down wholly owned subsidiary in Dubai through existing subsidiary TTI.
The shift from profit to loss and a sharp fall in profitability are negatives for shareholders, suggesting margin pressure and unresolved legacy receivables and legal exposures. The continued reliance on parent support for two loss-making subsidiaries and large ECL provisions point to underlying stress, while the Dubai subsidiary expansion and management restructuring signal an attempt to refocus on growth markets. Expect cautious near-term sentiment on the stock given weak Q1 numbers and unresolved contingent liabilities.